A perspective on investigational drug management.
The increasing prevalence of pharmacy-based IDSs is raising the awareness of sponsors to the value of involving pharmacists in the design and conduct of drug studies. We have participated in several privately sponsored multicenter studies that required pharmacy participation as a condition of site participation. Government agencies (i.e., NIAID) now require and fund pharmacy involvement in their research.